Pharmaceuticals 2011 - A Comparison in Terms and Application for Drugs and Biologics
Date2011-03-30
Deadline2011-03-30
VenuePalo Alto, USA - United States
KeywordsPharmaceuticals,conference,event,Webinar
Topics/Call fo Papers
Why Should You Attend:
In this seminar, the application of the terms GLP and GMP will be explored, as there is often confusion in their application during development. This seminar will define the terms and their application in the development environment.
During product development within an organization that has yet to commercialize a product, the use of the terms GLP and GMP are often confused and may be used incorrectly. Doing so can result in reducing credibility by regulatory health authorities. The objective of this seminar is to define the terms, how they are.
Areas Covered in the Seminar:
Nomenclature.
How the GLPs and GMPs came to be an their evolution.
The major sections of GMPs.
When to apply GMPs.
The major sections of GLPs.
When to apply the GLPs.
A comparison of the two.
Avoiding confusion.
NOTE: Use This Promocode ( 117660 ) To Get 10% Discount.
In this seminar, the application of the terms GLP and GMP will be explored, as there is often confusion in their application during development. This seminar will define the terms and their application in the development environment.
During product development within an organization that has yet to commercialize a product, the use of the terms GLP and GMP are often confused and may be used incorrectly. Doing so can result in reducing credibility by regulatory health authorities. The objective of this seminar is to define the terms, how they are.
Areas Covered in the Seminar:
Nomenclature.
How the GLPs and GMPs came to be an their evolution.
The major sections of GMPs.
When to apply GMPs.
The major sections of GLPs.
When to apply the GLPs.
A comparison of the two.
Avoiding confusion.
NOTE: Use This Promocode ( 117660 ) To Get 10% Discount.
Other CFPs
- Submission Documentation for Sterilization Process Validation
- Designing an effective cleaning validation in today's regulatory environment
- Sterilization Options for Challenging Products
- The Use and Mis-use of FMEA in Medical Device Risk Management
- The FDA’s (MDDS)final rule and its implications for currently regulated and unregulated vendors and providers
Last modified: 2011-03-11 19:52:43